The IHC assay of lung metastatic tumors revealed that knockdown of COL10A1 enhanced the expression of E-cadherin (epithelial marker) and decreased the expression of Vimentin (mesenchymal marker), while there was not significant decrease in SOX9 expression (Fig. 5c). Here, SOX9 is linked to metastatic neoplasm.